(Q41116409)

27 September 2017

1 reference

title

Emerging resistance to antibiotics: impact on respiratory infections in the outpatient setting (English)

1 reference

27 September 2017

Green M

1

1 reference

27 September 2017

Wald ER

series ordinal

2

1 reference

27 September 2017

language of work or name

1 reference

1 September 1996

1 reference

Annals of Allergy, Asthma & Immunology

27 September 2017

published in

1 reference

27 September 2017

volume

77

1 reference

27 September 2017

issue

3

1 reference

27 September 2017

page(s)

167-73; quiz 173-5

1 reference

The crisis in antibiotic resistance

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

Bacterial resistance mechanisms as therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

Resistance to antibiotics mediated by target alterations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

Prevention of drug access to bacterial targets: permeability barriers and active efflux

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

Outer membrane barrier as a mechanism of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

Active efflux mechanisms for antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

1 reference

7 January 2021

Inactivation of antibiotics and the dissemination of resistance genes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

Cephalosporin antimicrobial agents and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

Cefpodoxime proxetil compared with amoxicillin-clavulanate for the treatment of otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

Serum sickness-like reactions associated with cefprozil therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

Tetracyclines, Chloramphenicol, Erythromycin, Clindamycin, and Metronidazole

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

Trimethoprim-sulfamethoxazole

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

Increasing incidence of penicillin- and ampicillin-resistant middle ear pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963250-4

7 January 2021

10.1016/S1081-1206(10)63250-4

Identifiers

DOI

1 reference

27 September 2017

1 reference